ABOUT US
Pioneering Global Regenerative Science & Technology
Essex Bio-Technology is a bio-pharmaceutical company that develops, manufactures and commercialises genetically engineered therapeutic rb-bFGF (FGF-2), having six commercialized biologics marketed in China since 1998. The products of the Company are principally prescribed for the treatment of wounds healing and diseases in Ophthalmology & Dermatology.
More
1
Pioneer & Leader in Growth Factor
1st global rb-bFGF drug — Beifuji
1st global rb-bFGF eye drops — Beifushu
1st global rb-bFGF eye drops — Beifushu
2
Solid APIs & R&D Capability
Various proprietary APIs
Diversified pipeline primarily in ophthalmology
Honoured with the second prize of National Scientific and Technology Progress Award in 2004 and 2018
Diversified pipeline primarily in ophthalmology
Honoured with the second prize of National Scientific and Technology Progress Award in 2004 and 2018
3
Entrenched Market Foothold
9760 hospitals under sales & distribution coverage in China
Market leader of growth factor drugs in Ophthalmology and Dermatology arena
Market leader of growth factor drugs in Ophthalmology and Dermatology arena
R&D
Tomorrow's today
4 In-house R&D platforms：
· Growth Factor
· Antibody
· Drug Formulation
· Blow-Fill-Seal (BFS)
Leveraging on its in-house R&D platform，the Company maintains a pipeline of projects in various clinical stages, covering a wide range of fields of indication
More
· Growth Factor
· Antibody
· Drug Formulation
· Blow-Fill-Seal (BFS)
Leveraging on its in-house R&D platform，the Company maintains a pipeline of projects in various clinical stages, covering a wide range of fields of indication
R&D
Tomorrow's today
4 In-house R&D platforms：
· Growth Factor
· Antibody
· Drug Formulation
· Blow-Fill-Seal (BFS)
Leveraging on its in-house R&D platform，the Company maintains a pipeline of projects in various clinical stages, covering a wide range of fields of indication
More
· Growth Factor
· Antibody
· Drug Formulation
· Blow-Fill-Seal (BFS)
Leveraging on its in-house R&D platform，the Company maintains a pipeline of projects in various clinical stages, covering a wide range of fields of indication
PRODUCTS
Harnessing Innovations to Deliver Unmet Drugs for Blessing of People at Large
We are dedicated to deliver products in Ophthalmology and Surgical arena, including three flagship product series: Beifushu, Beifuji and Beifuxin, which are prescribed for the treatment of wounds healing and diseases in Ophthalmology and Dermatology.
Information is solely for medical professionals.
Beifushu Eye Drops
Beifushu is a national category I new drug developed and manufactured by Zhuhai Essex Bio-Pharmaceutical Co.,Ltd., the first domestic eye drops that can stimulate corneal reparation and improve healing quality of cornea.
More
Beifushu Eye Gel
Beifushu eye gel is a genetically engineered new drug developed and manufactured by Zhuhai Essex Bio-Pharmaceutical Co., Ltd.. Carbomer -a new generation of artificial tears, as a new matrix of the eye gel, can give patients a sustainable relief.
With the effect of bFGF, Beifushu eye gel can stimulate corneal reparation and improve healing quality of cornea, keeping cornea in homeostasis.
More
With the effect of bFGF, Beifushu eye gel can stimulate corneal reparation and improve healing quality of cornea, keeping cornea in homeostasis.
Unit-dose Beifushu Eye Drops
Unit-dose Befushu eye drops is a genetically engineered new drug developed and manufactured by Zhuhai Essex Bio-Pharmaceutical Co., Ltd.. As the third generation of Beifushu Series, it is a preservative-free formulation potentially delivering best treatment outcomes to patients.
More
Beifuji Spray
Beifuji is a national category I new drug developed and manufactured by Zhuhai Essex Bio-Pharmaceutical Co.,Ltd..
The API of Beifuji Spray is recombinant bovine basic fibroblast growth factor (rb-bFGF) – a multifunctional growth factor with a wide range of bioactivities, which can stimulate the proliferation and differentiation of cells in the process of wound healing and further improve the healing quality.
More
The API of Beifuji Spray is recombinant bovine basic fibroblast growth factor (rb-bFGF) – a multifunctional growth factor with a wide range of bioactivities, which can stimulate the proliferation and differentiation of cells in the process of wound healing and further improve the healing quality.
Beifuji Lyophilized Powder
Beifuji Lyophilized Powder is a national category I new drug developed and manufactured by Zhuhai Essex Bio-Pharmaceutical Co.,Ltd..
The API of Beifuji Lyophilized Powder is recombinant bovine basic fibroblast growth factor (rb-bFGF) – a multifunctional growth factor with a wide range of bioactivities, which can stimulate the proliferation and differentiation of cells in the process of wound healing and further improve the healing quality.
More
The API of Beifuji Lyophilized Powder is recombinant bovine basic fibroblast growth factor (rb-bFGF) – a multifunctional growth factor with a wide range of bioactivities, which can stimulate the proliferation and differentiation of cells in the process of wound healing and further improve the healing quality.
Beifuxin Gel
Beifuxin gel is a genetically engineered new drug developed and manufactured by Zhuhai Essex Bio-Pharmaceutical Co., Ltd..
The API of Beifuxin is recombinant bovine basic fibroblast growth factor (rb-bFGF) - a multifunctional growth factor with a wide range of bioactivity, which can stimulate the proliferation and differentiation of cells involved in wound healing.
More
The API of Beifuxin is recombinant bovine basic fibroblast growth factor (rb-bFGF) - a multifunctional growth factor with a wide range of bioactivity, which can stimulate the proliferation and differentiation of cells involved in wound healing.
Essex Bio-Technology to Present at the 5th China Bio-Pharm Partnering Forum (Bio-Pharm 2021)
2021.10.27
Application for Clinical Trial of Bevacizumab Has Been Approved for the Treatment of wAMD in Latvia
2021.04.20
